Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (7)
2021
-
Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884] (Journal of Hepatology (2019) 70(5) (874–884), (S0168827819300157), (10.1016/j.jhep.2019.01.005))
Journal of Hepatology
-
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH
Medicina Clinica, Vol. 156, Núm. 9, pp. 463.e1-463.e30
-
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice
European Journal of Radiology, Vol. 135
2020
-
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
Liver International, Vol. 40, Núm. 6, pp. 1467-1476
2019
-
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
Journal of Hepatology, Vol. 70, Núm. 5, pp. 874-884
2018
-
Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events
Hepatology, Vol. 67, Núm. 2, pp. 612-622
2016
-
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Journal of Hepatology, Vol. 65, Núm. 4, pp. 719-726